Overview

Daytime Impact Sleep Study

Status:
Terminated

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

This trial will investigate the relationship of sleep, daytime performance and nocturia in patients treated with Desmopressin or placebo. Male and Female patients will be administered Desmopressin or Placebo every day for 3 months.

Phase:

Phase 2

Details

Lead Sponsor:

Ferring Pharmaceuticals

Treatments:

Deamino Arginine Vasopressin